切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2015, Vol. 04 ›› Issue (03) : 187 -190. doi: 10.3877/cma.j.issn.2095-3232.2015.03.013

所属专题: 文献

基础研究

siRNA沉默c-jun基因对肝硬化大鼠肝切除术后肝再生的影响及其机制
杨跃武1, 刘旭辉2, 孔庆磊2, 叶志强2,()   
  1. 1. 510630 广州,中山大学附属第三医院中医科
    2. 510630 广州,中山大学附属第三医院急诊科
  • 收稿日期:2015-02-10 出版日期:2015-06-10
  • 通信作者: 叶志强
  • 基金资助:
    广东省科技计划项目(2011B61300011)

Influence and mechanism of c-jun gene silenced by siRNA on liver regeneration in liver cirrhotic rats after hepatectomy

Yuewu Yang1, Xuhui Liu2, Qinglei Kong2, Zhiqiang Ye2,()   

  1. 1. Department of Traditional Chinese Medicine, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
    2. Department of Emergency, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China
  • Received:2015-02-10 Published:2015-06-10
  • Corresponding author: Zhiqiang Ye
  • About author:
    Corresponding author: Ye Zhiqiang, Email:
引用本文:

杨跃武, 刘旭辉, 孔庆磊, 叶志强. siRNA沉默c-jun基因对肝硬化大鼠肝切除术后肝再生的影响及其机制[J/OL]. 中华肝脏外科手术学电子杂志, 2015, 04(03): 187-190.

Yuewu Yang, Xuhui Liu, Qinglei Kong, Zhiqiang Ye. Influence and mechanism of c-jun gene silenced by siRNA on liver regeneration in liver cirrhotic rats after hepatectomy[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2015, 04(03): 187-190.

目的

探讨siRNA沉默c-jun基因对肝硬化大鼠肝切除术后肝再生的影响及其机制。

方法

建立肝硬化大鼠模型,采用随机数字表法将50只肝硬化大鼠随机分为治疗组和对照组,每组25只。治疗组行肝大部分切除术的同时门静脉内注射慢病毒包装的Pcmv6-AC-GFP/c-jun-siRNA质粒。对照组行肝大部分切除术的同时门静脉内注射PBS。两组大鼠于术后14 d检测门静脉压力、血清ALT及肝重量体重比,采用Western blot法检测肝脏c-jun和增殖细胞核抗原(PCNA)蛋白相对表达量。两组间的数据比较采用t检验。

结果

治疗组术后平均门静脉压力为(1.18±0.11) kPa,明显小于对照组的(1.67±0.24) kPa(t=-26.74,P<0.05)。治疗组术后ALT为(43±5)U/L,明显低于对照组的(257±14)U/L(t=-31.11,P<0.05)。治疗组术后肝重量体重比为(6.94±0.31)%,明显大于对照组的(2.76±0.14)%(t=23.57,P<0.05)。治疗组术后c-jun和PCNA蛋白相对表达量分别为0.143±0.014、0.195±0.027,对照组相应为0.742±0.057、0.029±0.003,差异有统计学意义(t=-37.17,14.86;P<0.05)。

结论

慢病毒负载的c-jun-siRNA可能通过下调肝细胞c-jun,上调PCNA蛋白表达来促进肝再生,改善肝硬化大鼠肝切除术后肝功能。

Objective

To investigate the influence and mechanism of c-jun gene silenced by siRNA on liver regeneration in liver cirrhotic rats after hepatectomy.

Methods

Liver cirrhotic rat models were established and 50 liver cirrhotic rats were randomized into the treatment group and the control group by random number table method with 25 rats in each group. The rats in the treatment group underwent major hepatectomy and were administered with lentivirus carrying plasmid Pcmv6-AC-GFP/ c-jun-siRNA by intraportal injection, while the rats in the control group underwent major hepatectomy and were administered with phosphate buffer saline (PBS) by intraportal injection. The portal pressure, serum ALT and liver weight/body weight of both groups were tested 14 d after surgery. The relative expression of c-jun in the liver and proliferating cell nuclear antigen (PCNA) protein was detected by Western blot. The data between the treatment group and the control group were compared using t test.

Results

The average portal pressure of the treatment group after surgery was (1.18±0.11) kPa, which was significantly lower than (1.67±0.24) kPa of the control group (t=-26.74, P<0.05). ALT of the treatment group after surgery was (43±5) U/L, which was significantly lower than (257±14) U/L of the control group (t=-31.11, P<0.05). Liver weight/body weight of the treatment group after surgery was (6.94±0.31)%, which was significantly greater than (2.76±0.14)% of the control group (t=23.57, P<0.05). The relative expression of c-jun and PCNA protein of the treatment group after surgery was respectively 0.143±0.014 and 0.195±0.027, and those of the control group was respectively 0.742±0.057 and 0.029±0.003, where significant difference was observed (t=-37.17, 14.86; P<0.05).

Conclusion

Lentivirus carrying c-jun-siRNA may promote liver regeneration and improve live function in cirrhotic rats after hepatectomy by down-regulating the c-jun in hepatocyte and up-regulating the PCNA protein.

[1]
Shi R, Zhang YM, Zhu ZJ, et al. Synchronous splenectomy and hepatectomy in patients with hepatocellular carcinoma, hypersplenism and liver cirrhosis[J]. Hepatogastroenterology, 2014, 61(133):1363-1367.
[2]
马心逸,刘巧云,喻智勇.血流力学信号与肝再生的研究进展[J]. 中华消化外科杂志,2014, 13(3): 237-240.
[3]
Yang QH, Hu SP, Zhang YP, et al. Effects of different therapeutic methods and typical recipes of Chinese medicine on activation of c-Jun N-terminal kinase in kupffer cells of rats with fatty liver disease[J]. Chin J Integr Med, 2012, 18(10):769-774.
[4]
袁晟光,梁科伟,刘杰,等.不同引流方式对梗阻性黄疸大鼠部分肝切除术后肝再生的影响[J].中华消化外科杂志,2013, 12(12):956-962.
[5]
刘立宝,黄蕾,张军航,等.Caspase-3 siRNA减少骨髓间充质干细胞稳定株细胞凋亡的实验研究[J].器官移植,2014,5(5):283-288.
[6]
Morise Z, Sugioka A, Kawabe N, et al. Pure laparoscopic hepatectomy for hepatocellular carcinoma patients with severe liver cirrhosis[J]. Asian J Endosc Surg, 2011, 4(3):143-146.
[7]
Xue XJ, Zhou S, Li RR, et al. Vascular exclusion by preserving tumor-contralateral branch of hepatic artery in hepatectomy in treatment liver cancer with cirrhosis[J]. Hepatogastroenterology, 2012, 59(117):1366-1367.
[8]
耿明凡,高方媛,谷莉莉,等.终末期肝病的模型与评价指标的研究进展[J/CD].中国肝脏病杂志:电子版,2014, 6(3):98-100.
[9]
Li C, Mi K, Wen TF, et al. Outcome comparison of right hepatectomy for living liver donation versus for hepatic patients without cirrhosis[J]. J Gastrointest Surg, 2011, 15(6):982-987.
[10]
Cao J, Luo SM, Liang L, et al. Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis[J]. JPEN J Parenter Enteral Nutr, 2007, 31(6):496-501.
[11]
乔建梁,刘补报,张俊晶,等.显微镜下大鼠70%肝切除模型的制备[J].内蒙古医科大学学报,2014, 36(4):302-305.
[12]
郑玉宝,高志良.干细胞移植在肝衰竭治疗的现况及前景[J].临床内科杂志,2014,31(8): 523-525.
[13]
Wang W, Du Z, Yan J, et al. Mesenchymal stem cells promote liver regeneration and prolong survival in small-for-size liver grafts: involvement of C-Jun N-terminal kinase, cyclin D1, and NF-κB[J]. PLoS One, 2014, 9(12):e112532.
[14]
Mcgill MR, Du K, Xie Y, et al. The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury[J]. Xenobiotica, 2014, DOI: 10.3109/00498254.2014.986250[Epub ahead of print].
[15]
潘华,景海娟.乌司他丁和前列地尔在肝硬化并肾病综合征患者行肝移植手术中保护性研究[J].河南外科学杂志,2014,20(5):71-72.
[16]
Li Y, Ma J, Fang Q, et al. C-fos and c-jun expression in the liver of silver carp and the effect of microcystins[J]. J Biochem Mol Toxicol, 2014, 28(4):157-166.
[17]
Ferreira DM, Afonso MB, Rodrigues PM, et al. C-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver[J]. Mol Cell Biol, 2014, 34(6):1100-1120.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[3] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[8] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[9] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[10] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[11] 张金华, 赵锁. 早期ICC腹腔镜肝切除术不同淋巴结清扫范围的近远期效果对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 578-581.
[12] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[13] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[14] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[15] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
阅读次数
全文


摘要